Note 8: Income tax

Pre-tax income from continuing operations amounted to a profit of €573 million (2017: €764 million). The net tax charges related to continuing operations are included in the statement of income as follows:

Classification of current and deferred tax result

In € millions

2017

2018

 

 

 

Current tax expense for

 

 

The year

(158)

(121)

Adjustments for previous years

56

23

Separation of Specialty Chemicals business

(1)

(4)

Total current tax expense

(103)

(102)

 

 

 

Deferred tax expense for

 

 

US tax reform

(56)

Separation of Specialty Chemicals business

(32)

44

Origination and reversal of temporary differences and tax losses

(44)

(48)

(De)recognition of deferred tax assets

(12)

(9)

Changes in tax rates

(6)

(3)

Total deferred tax expense

(150)

(16)

Total

(253)

(118)

The total deferred tax charge, including discontinued operations was €143 million (2017: €182 million). The total tax charge, including discontinued operations, was €549 million (2017: €422 million).

Effective tax rate reconciliation

The effective income tax rate based on the statement of income is 20.6%.

Effective tax rate

in %

2017

2018

Corporate tax rate in the Netherlands

25.0

25.0

Effect of tax rates in other countries

(1.0)

(0.1)

Weighted average statutory income tax rate

24.0

24.9

US tax reform

7.3

0.0

Separation of Specialty Chemicals business

4.2

(7.0)

Non-taxable (income)/expenses

0.7

2.4

(De)recognition of deferred tax assets

1.6

1.6

Non-refundable withholding taxes

1.8

2.3

Adjustment for prior years

(7.3)

(4.0)

Other

0.8

0.4

Effective tax rate

33.1

20.6

For comparison reasons, the above table presents the effective consolidated tax rate excluding the impact of results on discontinued operations. Including these results, the effective consolidated tax rate is 7.5%, as the deal result is largely tax exempted, refer to Note 2.

The benefits arising from previously unrecognized tax losses, tax credit or temporary differences of a prior period that are used to reduce the current tax expense in 2018 amounted to €25 million and to reduce the deferred tax expense to €20 million. These mainly related to the separation of the Specialty Chemicals business.

The impact of non-refundable withholding tax on the tax rate is dependent on our relative share in the profit of subsidiaries in countries that levy withholding tax on dividends and on the timing of the remittance of such dividends. Based on the Dutch tax system there is a limited credit for such taxes.

The adjustments for prior years are mainly related to the outcome of several tax audits.

Deferred tax assets and liabilities

From the total amount of recognized net deferred tax assets, €393 million (2017: €280 million) is related to entities that have suffered a loss in either 2018 or 2017 and where utilization is dependent on future taxable profit in excess of the profit arising from the reversal of existing taxable temporary differences. This assessment is based on management’s long-term projections and tax planning strategies.

A deferred tax liability is recognized for taxable temporary differences related to investments in subsidiaries, branches and associates and interests in joint arrangements, to the extent that it is probable that these will reverse in the foreseeable future. The expected net tax impact of the remaining differences for which no deferred tax liabilities have been recognized is €30 million.

Deferred tax assets and liabilities

In € millions

2017

2018

*

Excluding discontinued operations charge of €1 million.

Deferred tax assets

1,017

575

Deferred tax liabilities

(367)

(285)

Balance at December 31 prior year

650

290

Impact of adoption IFRS 15

16

Impact of adoption IFRS 9

1

Impact of application IAS 29*

(6)

Balance at January 1

650

301

Movement in deferred tax:

 

 

Changes in exchange rates

(19)

9

Recognized in income

(182)

(143)

Recognized in equity/
Other comprehensive income

(105)

40

Classified as held for sale

(52)

(6)

Other

(2)

(10)

Balance at December 31

290

191

Deferred tax assets

575

559

Deferred tax liabilities

(285)

(368)

Expiration year of loss carryforwards

In € millions

2019

2020

2021

2022

2023

Later

Unlimited

Total

Total loss carryforwards

1

1

1

33

155

267

2,674

3,132

Loss carryforwards not recognized in deferred tax assets

(31)

(74)

(105)

Total recognized

1

1

1

33

155

236

2,600

3,027

Deferred tax assets and liabilities per balance sheet item

 

December 31, 2017

December 31, 2018

In € millions

Net balance

Assets

Liabilities

Net balance

Assets

Liabilities

Intangible assets

(368)

17

385

(363)

28

391

Property, plant and equipment

43

69

26

47

75

28

Post-retirement benefit provisions

177

179

2

121

124

3

Other provisions

47

59

12

37

49

12

Other items and tax credits

162

248

86

71

261

190

Tax loss carryforwards

593

593

582

582

Deferred tax assets not recognized

(364)

(364)

(304)

(304)

Tax assets/liabilities

290

801

511

191

815

624

Set-off of tax

(226)

(226)

(256)

(256)

Net deferred taxes

290

575

285

191

559

368

Unrecognized deferred tax assets

In € millions

2017

2018

Tax losses and tax credits

193

167

Deductible temporary differences

171

137

Total

364

304

The income tax recognized in equity in 2017 includes the impact of a derecognition and in 2018 of a rerecognition of certain post-retirement benefits related deferred tax assets.

Income tax recognized in equity

In € millions

2017

2018

Currency exchange differences on intercompany loans of a permanent nature

(5)

17

Cash flow hedges

(4)

5

Share-based compensation

3

(1)

Post-retirement benefits

(99)

24

Impact of adoption IFRS 15

16

Impact of adoption IFRS 9

1

Impact of application IAS 29

(7)

Total

(105)

55

Current tax

5

Deferred tax

(105)

50

Total

(105)

55